Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)

NCT04780854 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04780854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04780854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)
Lead sponsor
Cairo University
Phase
Phase 2
Overall status
Unknown status
Start date
November 3, 2020
Completion date
July 31, 2022
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy